Four of Acorda’s Ampyra patents invalidated

03-04-2017

Four of Acorda’s Ampyra patents invalidated

tomloel / iStockphoto.com

A Delaware district court has invalidated four patents owned by Acorda Therapeutics after the company and Alkermes Pharma Ireland alleged that Apotex, Mylan, Roxane Laboratories and Teva infringed them.


Ampyra, Acorda, Alkermes, Apotex, Mylan, Teva, patent, invalidated, multiple sclerosis

More on this story

BIO and PhRMA back Acorda in patent appeal
17-08-2017

LSIPR